Finance
According to the Ministry of Health and Family Welfare, intranasal vaccine – iNCOVACC – is now available for use in the private sector as part of the Covid-19 vaccination program (MoHFW).
The technical details of iNCOVACC are as follows:
Vaccine name: iNCOVACC; Manufacturer Name: Bharat Biotech (BBIL); Vaccine type: Intranasal; Vaccine description (Type): Covid-19 Vaccine, Intranasal Recombinant (Adenovirus Vector based); Dose per vial: Two doses; Eligible Beneficiaries 18 years and above: 18 Yrs and above for Primary Vaccination and third dose (Precaution Dose); Heterologous precaution dose for people of 18 years and above, after 6 months of primary vaccination (two doses) of Covaxin or Covishield.
Doses per beneficiary: 0.5ml per dose in 8 drops, (4 drops in each nostril); No. of Doses: Two doses for primary schedule
Dose Frequency: 28 days apart (Primary schedule)
According to MoHFW, the necessary changes on Co-WIN platform for same are being made.
Source:OCN
